126 related articles for article (PubMed ID: 35435392)
21. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
Beach R; Gown AM; De Peralta-Venturina MN; Folpe AL; Yaziji H; Salles PG; Grignon DJ; Fanger GR; Amin MB
Am J Surg Pathol; 2002 Dec; 26(12):1588-96. PubMed ID: 12459625
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
Hameed O; Sublett J; Humphrey PA
Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
[TBL] [Abstract][Full Text] [Related]
23. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
Jiang Z; Li C; Fischer A; Dresser K; Woda BA
Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
[TBL] [Abstract][Full Text] [Related]
24. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
Zhou M; Jiang Z; Epstein JI
Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
[TBL] [Abstract][Full Text] [Related]
25. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
Baydar DE; Kulac I; Gurel B; De Marzo A
Int J Surg Pathol; 2011 Feb; 19(1):131-6. PubMed ID: 20719821
[TBL] [Abstract][Full Text] [Related]
26. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
27. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Paner GP; Luthringer DJ; Amin MB
Arch Pathol Lab Med; 2008 Sep; 132(9):1388-96. PubMed ID: 18788849
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials.
Kuroda N; Katto K; Tamura M; Shiotsu T; Nakamura S; Ohtsuki Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH
Med Mol Morphol; 2010 Sep; 43(3):165-9. PubMed ID: 20857265
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer with aberrant diffuse p63 expression: report of a case and review of the literature and morphologic mimics.
Wu A; Kunju LP
Arch Pathol Lab Med; 2013 Sep; 137(9):1179-84. PubMed ID: 23991727
[TBL] [Abstract][Full Text] [Related]
30. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
31. p63 as a complimentary basal cell specific marker to high molecular weight-cytokeratin in distinguishing prostatic carcinoma from benign prostatic lesions.
Shiran MS; Tan GC; Sabariah AR; Rampal L; Phang KS
Med J Malaysia; 2007 Mar; 62(1):36-9. PubMed ID: 17682568
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
33. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
Xiao GQ; Burstein DE; Miller LK; Unger PD
Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical algorithms in prostate diagnostics: what's new?].
Kristiansen G
Pathologe; 2009 Dec; 30 Suppl 2():146-53. PubMed ID: 19795124
[TBL] [Abstract][Full Text] [Related]
35. Use of p63/P504S monoclonal antibody cocktail in immunohistochemical staining of prostate tissue.
Tacha DE; Miller RT
Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):75-8. PubMed ID: 15163024
[TBL] [Abstract][Full Text] [Related]
36. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.
Tan HL; Haffner MC; Esopi DM; Vaghasia AM; Giannico GA; Ross HM; Ghosh S; Hicks JL; Zheng Q; Sangoi AR; Yegnasubramanian S; Osunkoya AO; De Marzo AM; Epstein JI; Lotan TL
Mod Pathol; 2015 Mar; 28(3):446-56. PubMed ID: 25216229
[TBL] [Abstract][Full Text] [Related]
37. The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens.
Helpap B
Virchows Arch; 2006 Apr; 448(4):480-4. PubMed ID: 16506014
[TBL] [Abstract][Full Text] [Related]
38. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI
Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245
[TBL] [Abstract][Full Text] [Related]
39. Histopathological features of intra-ductal carcinoma of prostatic and high grade prostatic intraepithelialneoplasia and correlation with PTEN and P63.
Torabi-Nezhad S; Malekmakan L; Mashayekhi M; Daneshian A
Prostate; 2016 Mar; 76(4):394-401. PubMed ID: 26643011
[TBL] [Abstract][Full Text] [Related]
40. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion.
Herawi M; Parwani AV; Irie J; Epstein JI
Am J Surg Pathol; 2005 Jul; 29(7):874-80. PubMed ID: 15958851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]